A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
Launched by TELEFLEX · Sep 16, 2024
Trial Information
Current as of November 08, 2025
Recruiting
Keywords
ClinConnect Summary
The Teleflex Vascular Access Device Registry (VADER) is a clinical trial designed to gather important information about the safety and effectiveness of Teleflex's vascular access devices, which are used to help deliver medications and fluids to patients. The goal is to see how these devices perform in real-life situations outside of a controlled clinical setting. This study will help ensure that patients receive the best possible care when these devices are used.
To participate in this trial, individuals must be undergoing a procedure that involves a Teleflex device and be willing to give consent for their health information to be collected. Participants should be able to read and understand either English or Spanish. However, those currently involved in other clinical studies, those who have previously enrolled or failed screening for this registry, individuals who are imprisoned, or those who are unable to make decisions due to cognitive impairments will not be eligible to join. This trial is still in the planning stages and is not yet recruiting participants, but it aims to provide valuable insights for improving patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research.
- • Subject is willing and capable of providing informed consent and/or give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation.
- • Subjects is able to read and understand English or Spanish languages
- Exclusion Criteria:
- • Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry.
- • Subject was previously failed screening or was enrolled in this clinical Registry.
- • Subject is imprisoned
- • Subject is cognitively impaired and unable to provide informed consent
About Teleflex
Teleflex is a global provider of medical technologies that enhance clinical outcomes for healthcare providers and patients. With a diverse portfolio of innovative products and solutions, Teleflex specializes in areas such as vascular access, anesthesia, urology, and surgical instrumentation. Committed to improving patient care, the company focuses on advancing medical devices through rigorous research and development, including robust clinical trials that ensure the safety and efficacy of their offerings. Teleflex's dedication to quality, innovation, and collaboration positions it as a trusted partner in the healthcare community, striving to meet the evolving needs of clinicians and patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Huntsville, Alabama, United States
Loma Linda, California, United States
Patients applied
Trial Officials
Amy Bardin
Study Director
Teleflex Incorporated Clinical and Medical Affairs
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported